BIOJECT MEDICAL TECHNOLOGIES INC 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Apr 26, 2010
Insider Transaction Report
Form 4
FARRELL CHRISTINE
VP of Finance
Transactions
- Award
Stock Option (Right-to-buy)
2010-04-23+150,000→ 269,171 totalExercise: $0.30Exp: 2017-04-22→ BJCT Common Stock (150,000 underlying)
Holdings
- 85,741(indirect: By 401(k))
BJCT Common Stock
- 254,024
BJCT Common Stock
Footnotes (2)
- [F1]50% to vest immediately, 25% to vest 4/23/11 and 25% to vest 4/23/12
- [F2]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 194,071, Restricted Stock Unit 64,000